Nifty
Sensex
:
:
8083.80
27590.95
-170.00 (-2.06%)
-674.36 (-2.39%)

Pharmaceuticals & Drugs

Rating :
73/99  (View)

BSE: 506943 | NSE: JBCHEPHARM

447.30
-58.30 (-11.53%)
03-Apr-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  489.00
  •  489.00
  •  440.45
  •  505.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  339700
  •  1519.48
  •  599.90
  •  311.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,463.78
  • 12.90
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,452.78
  • 1.12%
  • 2.28

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.68%
  • 0.88%
  • 18.95%
  • FII
  • DII
  • Others
  • 7.11%
  • 13.08%
  • 4.30%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.16
  • 7.18
  • 7.79

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.63
  • 8.34
  • 5.67

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.07
  • 9.90
  • 1.72

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.05
  • 16.33
  • 16.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.69
  • 2.69
  • 2.69

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.35
  • 9.85
  • 9.78

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
429
0
0
456
0
0
446
0
0
419
0
0
Expenses
339
0
0
356
0
0
350
0
0
354
0
0
EBITDA
90
0
0
100
0
0
96
0
0
65
0
0
EBIDTM
21%
0%
22%
0%
22%
0%
16%
0%
Other Income
16
0
0
19
0
0
13
0
0
16
0
0
Interest
1
0
0
1
0
0
1
0
0
1
0
0
Depreciation
17
0
0
16
0
0
16
0
0
12
0
0
PBT
88
0
0
102
0
0
92
0
0
68
0
0
Tax
22
0
0
8
0
0
30
0
0
21
0
0
PAT
66
0
0
94
0
0
62
0
0
47
0
0
PATM
16%
0%
21%
0%
14%
0%
11%
0%
EPS
8.26
0.00
0
11.67
0.00
0
7.73
0.00
0
5.82
0.00
0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
1,750
1,643
1,414
1,368
1,232
1,144
1,022
866
802
891
757
Net Sales Growth
0%
16%
3%
11%
8%
12%
18%
8%
-10%
18%
 
Cost Of Goods Sold
648
596
542
552
491
341
414
372
320
277
179
Gross Profit
1,102
1,047
871
816
740
803
608
495
482
614
578
GP Margin
63%
64%
62%
60%
60%
70%
59%
57%
60%
69%
76%
Total Expenditure
1,399
1,338
1,215
1,136
1,026
964
874
760
702
698
590
Power & Fuel Cost
-
63
58
55
55
53
47
40
30
23
18
% Of Sales
-
4%
4%
4%
4%
5%
5%
5%
4%
3%
2%
Employee Cost
-
288
251
217
175
160
144
130
113
125
92
% Of Sales
-
18%
18%
16%
14%
14%
14%
15%
14%
14%
12%
Manufacturing Exp.
-
150
140
131
119
224
102
62
53
61
103
% Of Sales
-
9%
10%
10%
10%
20%
10%
7%
7%
7%
14%
General & Admin Exp.
-
53
54
42
35
32
32
28
31
38
46
% Of Sales
-
3%
4%
3%
3%
3%
3%
3%
4%
4%
6%
Selling & Distn. Exp.
-
114
87
78
73
75
74
56
69
132
110
% Of Sales
-
7%
6%
6%
6%
7%
7%
6%
9%
15%
15%
Miscellaneous Exp.
-
73
82
60
77
79
62
73
86
42
110
% Of Sales
-
4%
6%
4%
6%
7%
6%
8%
11%
5%
6%
EBITDA
351
305
199
232
206
180
148
106
100
192
167
EBITDA Margin
20%
19%
14%
17%
17%
16%
14%
12%
13%
22%
22%
Other Income
63
41
55
50
57
11
38
28
29
6
14
Interest
3
4
3
5
11
7
6
5
24
10
12
Depreciation
61
56
57
47
41
39
28
25
22
23
22
PBT
350
287
194
230
211
146
152
104
83
165
148
Tax
81
93
55
46
50
45
26
24
166
26
29
Tax Rate
23%
32%
28%
20%
24%
31%
30%
23%
20%
16%
20%
PAT
269
193
138
184
161
100
62
79
678
139
119
PAT before Minority Interest
269
194
139
184
161
100
62
79
678
139
119
Minority Interest
-1
0
0
0
0
0
0
0
0
0
0
PAT Margin
15%
12%
10%
13%
13%
9%
6%
9%
85%
16%
16%
PAT Growth
0%
40%
-25%
14%
60%
63%
-23%
-88%
387%
17%
 
Unadjusted EPS
33.48
23.54
16.48
21.70
19.14
11.84
7.26
9.38
80.11
16.50
14.08

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
1,480
1,442
1,364
1,184
995
1,043
1,020
970
692
568
Share Capital
16
17
17
17
17
17
17
17
17
17
Total Reserves
1,464
1,425
1,347
1,167
978
1,026
1,003
953
674
551
Non-Current Liabilities
65
46
27
31
33
32
40
40
36
153
Secured Loans
0
0
0
0
0
0
0
0
1
98
Unsecured Loans
0
0
0
0
0
0
7
12
12
38
Long Term Provisions
6
10
13
10
12
12
8
8
8
0
Current Liabilities
781
736
693
797
460
276
239
188
271
117
Trade Payables
83
110
99
91
78
61
61
37
50
43
Other Current Liabilities
127
120
122
139
104
98
101
79
61
40
Short Term Borrowings
26
29
49
193
127
82
37
55
133
0
Short Term Provisions
545
477
423
375
152
36
41
17
27
34
Total Liabilities
2,328
2,226
2,086
2,014
1,487
1,351
1,300
1,198
999
837
Net Block
621
640
679
440
329
311
334
276
258
247
Gross Block
1,085
1,054
1,039
754
602
541
537
457
420
387
Accumulated Depreciation
464
414
359
314
273
230
203
180
162
140
Non Current Assets
741
718
879
832
586
370
356
332
279
271
Capital Work in Progress
15
17
4
135
55
46
5
39
4
0
Non Current Investment
96
50
186
231
185
3
3
3
4
24
Long Term Loans & Adv.
9
10
9
23
18
11
14
13
13
0
Other Non Current Assets
0
1
1
2
0
0
0
0
0
0
Current Assets
1,587
1,509
1,207
1,182
901
981
944
866
721
566
Current Investments
361
384
225
247
367
497
395
299
81
0
Inventories
244
214
200
188
150
134
105
101
112
84
Sundry Debtors
309
301
266
273
262
236
191
136
346
345
Cash & Bank
37
30
13
13
25
12
156
220
127
78
Other Current Assets
636
13
14
3
96
102
97
111
55
60
Short Term Loans & Adv.
605
568
488
459
96
101
97
110
55
60
Net Current Assets
806
772
514
385
441
704
704
678
449
450
Total Assets
2,328
2,226
2,086
2,014
1,487
1,351
1,300
1,198
999
837

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
193
123
201
140
127
-14
84
880
134
122
PBT
287
194
230
212
146
87
104
843
165
148
Adjustment
23
17
13
-1
39
21
-4
33
17
25
Changes in Working Capital
-52
-47
6
-17
-20
-94
9
167
-16
-23
Cash after chg. in Working capital
258
164
249
194
165
14
109
1,044
166
150
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-65
-41
-48
-53
-38
-28
-24
-164
-32
-28
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-27
-21
-45
-28
-112
-142
-116
-261
-89
-29
Net Fixed Assets
-30
-30
-153
-188
-70
-55
-42
-70
-33
-11
Net Investments
-23
-23
68
-14
-61
-102
-96
-214
-61
-17
Others
26
32
40
174
19
15
22
23
4
-2
Cash from Financing Activity
-155
-60
-184
-100
-1
12
-31
-526
5
-58
Net Cash Inflow / Outflow
11
43
-28
13
13
-144
-63
93
49
34
Opening Cash & Equivalents
21
-21
7
-5
12
156
220
127
78
44
Closing Cash & Equivalent
32
21
-21
9
25
12
156
220
127
78

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
184
172
161
140
117
123
119
113
81
67
ROA
9%
6%
9%
9%
7%
5%
6%
62%
15%
15%
ROE
13%
10%
14%
15%
10%
6%
8%
82%
22%
23%
ROCE
20%
14%
17%
18%
13%
8%
10%
92%
23%
24%
Fixed Asset Turnover
2
1
2
2
2
2
2
2
2
2
Receivable days
68
73
72
79
78
75
68
109
140
155
Inventory Days
51
53
52
50
45
42
43
48
40
39
Payable days
27
34
33
32
28
27
26
27
26
27
Cash Conversion Cycle
91
93
91
97
95
91
85
130
154
167
Total Debt/Equity
0
0
0
0
0
0
0
0
0
0
Interest Cover
69
57
44
21
22
16
21
36
17
14

News Update


  • JB Chemicals gets EIR from USFDA for manufacturing facility at Panoli
    11th Feb 2020, 11:01 AM

    At the end of the inspection, ‘No Objectionable Observation’ were found and no Form 483 was issued

    Read More
  • USFDA completes inspection at JB Chemicals & Pharmaceuticals’ Panoli facility
    10th Feb 2020, 12:14 PM

    This is the 10th consecutive successful inspection for this facility

    Read More
  • JB Chemicals gets nod to acquire entire trademarks portfolio of UPLL
    4th Feb 2020, 14:53 PM

    This transaction will be consummated before the end of this year

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.